PDS Planning Inc Buys 51 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

PDS Planning Inc raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% in the fourth quarter, Holdings Channel reports. The fund owned 1,385 shares of the medical equipment provider’s stock after purchasing an additional 51 shares during the quarter. PDS Planning Inc’s holdings in Intuitive Surgical were worth $723,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $31,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several recent research reports. Truist Financial lowered their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research note on Monday. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Raymond James increased their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Citigroup increased their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $610.19.

Intuitive Surgical Stock Up 0.9 %

Shares of ISRG opened at $488.80 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business’s fifty day moving average is $566.38 and its 200 day moving average is $531.96. The stock has a market cap of $174.10 billion, a P/E ratio of 76.26, a P/E/G ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.